» Authors » Rahail Ashraf

Rahail Ashraf

Explore the profile of Rahail Ashraf including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 54
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mandal T, Shukla D, Pattanayak S, Barman R, Ashraf R, Dixit A, et al.
ACS Omega . 2024 Dec; 9(50):48988-49000. PMID: 39713677
Cancer stem cells (CSCs) are responsible for chemoresistance and tumor relapse in many solid malignancies, including lung and ovarian cancer. Ellagic acid (EA), a natural polyphenol, exhibits anticancer effects on...
2.
Mohapatra O, Gopu M, Ashraf R, Easo George J, Patil S, Mukherjee R, et al.
Biomicrofluidics . 2024 Apr; 18(2):024107. PMID: 38606014
The utilization of 3D cell culture for spheroid formation holds significant implications in cancer research, contributing to a fundamental understanding of the disease and aiding drug development. Conventional methods such...
3.
Ashraf R, Kumar S
Cell Mol Life Sci . 2022 Oct; 79(11):573. PMID: 36308626
Mitochondrial dynamics are balanced fission and fusion events that regulate mitochondrial morphology, and alteration in these events results in mitochondrial dysfunction and contributes to many diseases, including tumorigenesis. Ovarian cancer...
4.
Thomas A, Swetha K, C K A, Ashraf R, Kumar J, Kumar S, et al.
J Mater Chem B . 2022 Aug; 10(33):6360-6371. PMID: 35946470
Template mediated assembly of plasmonic nanomaterials is a promising approach to induce chirality. Naturally occurring macromolecules can self-assemble to form chiral superstructures, with dimensions extending from nanometer to micrometer length...
5.
Cherukunnath A, Davargaon R, Ashraf R, Kamdar U, Srivastava A, Tripathi P, et al.
J Cell Biochem . 2022 Mar; 123(5):921-934. PMID: 35293014
Krüppel-like factor 8 (KLF8) is a transcription factor expressed abnormally in various cancer types and promotes oncogenic transformation. However, the role of KLF8 in ovarian cancer (OC) progression remains unclear....
6.
Kumar S, Ashraf R, C K A
Cell Biol Toxicol . 2022 Mar; 38(3):407. PMID: 35244813
No abstract available.
7.
Kumar S, Ashraf R, C K A
Cell Biol Toxicol . 2021 Oct; 38(3):377-406. PMID: 34661828
Regardless of the recent advances in therapeutic developments, cancer is still among the primary causes of death globally, indicating the need for alternative therapeutic strategies. Mitochondria, a dynamic organelle, continuously...
8.
Behera A, Ashraf R, Srivastava A, Kumar S
Heliyon . 2020 Sep; 6(9):e04820. PMID: 32984578
Background: Epithelial ovarian cancer (EOC) is a lethal and aggressive gynecological malignancy. Despite recent advances, existing therapies are challenged by a high relapse rate, eventually resulting in disease recurrence and...